These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 20513026
1. XRP6258-induced gene expression patterns in head and neck cancer carcinoma. Yoo GH, Kafri Z, Ensley JF, Lonardo F, Kim H, Folbe AJ, Won J, Stevens T, Lin HS. Laryngoscope; 2010 Jun; 120(6):1114-9. PubMed ID: 20513026 [Abstract] [Full Text] [Related]
5. An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma. Yoo GH, Subramanian G, Boinpally RR, Iskander A, Shehadeh N, Oliver J, Ezzat W, Piechocki MP, Ensley JF, Lin HS, Shibuya TY, Polin L, Parchment RE. Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):418-29. PubMed ID: 15897421 [Abstract] [Full Text] [Related]
9. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma. Kothari V, Mulherkar R. Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296 [Abstract] [Full Text] [Related]
10. Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models. Yoo GH, Subramanian G, Piechocki MP, Ensley JF, Kucuk O, Tulunay OE, Lonardo F, Kim H, Won J, Stevens T, Lin HS. Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):735-42. PubMed ID: 18645124 [Abstract] [Full Text] [Related]
15. Livin enhances chemoresistance in head and neck squamous cell carcinoma. Yoon TM, Kim SA, Lee DH, Lee JK, Park YL, Lee KH, Chung IJ, Joo YE, Lim SC. Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463 [Abstract] [Full Text] [Related]
16. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R. Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990 [Abstract] [Full Text] [Related]
17. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Crowe DL, Sinha UK. Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195 [Abstract] [Full Text] [Related]
18. Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. Umbreit C, Aderhold C, Faber A, Sommer JU, Sauter A, Hofheinz RD, Stern-Sträter J, Hoermann K, Schultz JD. Anticancer Res; 2013 Jun; 33(6):2457-65. PubMed ID: 23749896 [Abstract] [Full Text] [Related]
19. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. Patel V, Senderowicz AM, Pinto D, Igishi T, Raffeld M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS. J Clin Invest; 1998 Nov 01; 102(9):1674-81. PubMed ID: 9802881 [Abstract] [Full Text] [Related]
20. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Patel V, Lahusen T, Sy T, Sausville EA, Gutkind JS, Senderowicz AM. Cancer Res; 2002 Mar 01; 62(5):1401-9. PubMed ID: 11888912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]